Establishment of a patient-derived mucoepidermoid carcinoma cell line with the CRTC1-MAML2 fusion gene.

Establishment of a patient-derived mucoepidermoid carcinoma cell line with the CRTC1-MAML2 fusion gene.
复制标题

DOI:
10.3892/mco.2022.2508
复制
发表时间:
2022-03
影响因子:
1.2
通讯作者:
Nakano Y
Nakano Y
中科院分区:
其他
文献类型:
--
作者:
Noguchi K;Kanda S;Yoshida K;Funaoka Y;Yamanegi K;Yoshikawa K;Takaoka K;Kishimoto H;Nakano Y

文献摘要

参考文献

被引文献

相似文献

粘液表皮样癌是最常见的大、小涎腺恶性肿瘤。手术切除是唯一的治愈性治疗方法,目前尚无有效的术后治疗方法。本研究报告了一个机构审查委员会批准的情况下,45岁的日本女性诊断为低度MEC在硬腭。行根治性切除、肩胛舌骨上颈淋巴结清扫和股前外侧皮瓣重建。然后从切除的肿瘤组织建立MEC细胞系。短串联重复序列分析证实了该细胞系的起源和真实性,该细胞系含有CRTC 1-MAML 2易位,这在MEC中经常观察到。双调蛋白(AREG),确定为CRTC 1-MAML 2融合基因的目标之一,在细胞系中表达。AREG受体,表皮生长因子受体(EGFR)也高度磷酸化。结果预测,肿瘤生长和存活所需的AREG-EGFR信号传导可能以细胞自主的方式在细胞系中被激活。由于AREG表达与EGFR靶向耐药性相关,该细胞系可能有助于确定MEC治疗的新策略。
Mucoepidermoid carcinoma (MEC) is the most common malignant tumor of the major and minor salivary glands. Surgical resection is the only curative treatment and there is no effective post-operative therapy for MEC. The present study reports an Institutional Review Board-approved case of a 45-year-old Japanese female diagnosed with low-grade MEC in the hard palate. Radical resection, supraomohyoid neck dissection and antero-lateral thigh flap reconstruction was performed. A MEC cell line was then established from the resected tumor tissue. Short tandem repeat profiling confirmed the origin and authenticity of the cell line, that harbors a CRTC1-MAML2 translocation, which is frequently observed in MEC. Amphiregulin (AREG), identified as one of the targets of the CRTC1-MAML2 fusion gene, was expressed in the cell line. The AREG receptor, epidermal growth factor receptor (EGFR) was also highly phosphorylated. The results predicted that AREG-EGFR signaling, which is required for tumor growth and survival, might be activated in the cell line in a cell-autonomous manner. As AREG expression is associated with EGFR-targeted drug resistance, this cell line might assist with the identification of novel strategies for MEC treatment.
DOI: 10.1016/j.tibtech.2013.03.006
发表时间: 2013-06
影响因子: 17.3
作者:
Mitra A;Mishra L;Li S
通讯作者: Li S
DOI: 10.1007/s00894-015-2847-2
发表时间: 2015-12-01
影响因子: 2.2
作者:
Gupta, Rajat;Kalita, Prasanta;Mohanty, Sanat
通讯作者: Mohanty, Sanat
DOI: 10.1093/abbs/gmaa004
发表时间: 2020-04-01
影响因子: 3.7
作者:
Li, Xiaodong;Huang, Qingshan;Lin, Jianhua
通讯作者: Lin, Jianhua
DOI: 10.1038/modpathol.2009.126
发表时间: 2009-12-01
期刊: MODERN PATHOLOGY
影响因子: 7.5
作者:
Nakayama, Takahisa;Miyabe, Satoru;Inagaki, Hiroshi
通讯作者: Inagaki, Hiroshi
DOI: 10.1038/onc.2013.348
发表时间: 2014-07-17
期刊: ONCOGENE
影响因子: 8
作者:
Chen, Z.;Chen, J.;Wu, L.
通讯作者: Wu, L.